scholarly article | Q13442814 |
P2093 | author name string | M Jiang | |
L Kleiman | |||
M A Wainberg | |||
J Mak | |||
D Rekosh | |||
M L Hammarskjöld | |||
P2860 | cites work | Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 |
Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer | Q24630667 | ||
Mechanism and regulation of eukaryotic protein synthesis | Q24634693 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 | ||
Translational control in mammalian cells | Q28295830 | ||
Nucleotide Sequence of Three Isoaccepting Lysine tRNAs from Rabbit Liver and SV40-Transformed Mouse Fibroblasts | Q28322712 | ||
Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1 | Q28646853 | ||
Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. | Q30452154 | ||
RNA-directed DNA synthesis by the DNA polymerase of Rous sarcoma virus: structural and functional identification of 4S primer RNA in uninfected cells | Q35071982 | ||
Ability of tryptophan tRNA to hybridize with 35S RNA of avian myeloblastosis virus and to prime reverse transcription in vitro | Q35081163 | ||
Amino-acid acceptor activity of the "70S-associated" 4S RNA from avian myeloblastosis virus | Q35101670 | ||
Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly | Q35237462 | ||
Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNALys | Q35907165 | ||
Reactions at the termini of tRNA with T4 RNA ligase | Q36187051 | ||
Physical properties of Rous Sarcoma Virus RNA. | Q36473256 | ||
Selective Packaging of Host tRNA's by Murine Leukemia Virus Particles Does Not Require Genomic RNA | Q36491679 | ||
Reverse transcriptase as the major determinant for selective packaging of tRNA's into Avian sarcoma virus particles | Q36508415 | ||
Characterization of the low-molecular-weight RNAs associated with the 70S RNA of Rous sarcoma virus | Q36592321 | ||
Small RNAs of Rous sarcoma virus: characterization by two-dimensional polyacrylamide gel electrophoresis and fingerprint analysis | Q36596117 | ||
Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region. | Q36649979 | ||
Properties of avian retrovirus particles defective in viral protease | Q36784273 | ||
Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles | Q36807189 | ||
Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. | Q36855313 | ||
A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. | Q36899532 | ||
Reverse transcriptase of human immunodeficiency virus can use either human tRNA(3Lys) or Escherichia coli tRNA(2Gln) as a primer in an in vitro primer-utilization assay | Q37248161 | ||
Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis | Q37503153 | ||
Relationship of retrovirus polyprotein cleavages to virion maturation studied with temperature-sensitive murine leukemia virus mutants | Q37601580 | ||
Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication | Q38314018 | ||
An analysis of the role of tRNA species as primers for the transcription into DNA of RNA tumor virus genomes | Q39426675 | ||
Transfer RNA into RNA tumor viruses | Q39456157 | ||
The primer tRNA for Moloney murine leukemia virus DNA synthesis. Nucleotide sequence and aminoacylation of tRNAPro | Q39694410 | ||
A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis | Q39924625 | ||
tRNA's and priming of RNA-directed DNA synthesis in mouse mammary tumor virus | Q40307556 | ||
Association of 4S ribonucleic acid with oncornavirus ribonucleic acids | Q40635541 | ||
HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. | Q40819959 | ||
Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. | Q41107385 | ||
Variable tRNA content in HIV-1IIIB. | Q41618219 | ||
Isolation and fractionation of retroviral tRNAs | Q43444247 | ||
Nuclease footprinting of human immunodeficiency virus reverse transcriptase/tRNA(Lys-3) complexes | Q45786901 | ||
Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides | Q45873081 | ||
Lysine tRNA is the predominant tRNA in murine mammary tumor virus | Q45889818 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2065-2072 | |
P577 | publication date | 1994-04-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles | |
P478 | volume | 68 |
Q40468614 | Ability of wild-type and mutant lysyl-tRNA synthetase to facilitate tRNA(Lys) incorporation into human immunodeficiency virus type 1. |
Q33780519 | Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation |
Q40175403 | Analysis of the replication of HIV-1 forced to use tRNAMet(i) supports a link between primer selection, translation and encapsidation |
Q50289271 | Annealing of 3'-end of unwound transfer RNA primer with genomic RNA |
Q42211152 | Annealing to sequences within the primer binding site loop promotes an HIV-1 RNA conformation favoring RNA dimerization and packaging |
Q38018767 | Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA. |
Q35857341 | Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAs |
Q35123403 | Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly |
Q52347430 | Characterization of association of human mitochondrial lysyl-tRNA synthetase with HIV-1 Pol and tRNA3Lys. |
Q34751283 | Cleavage of the HIV replication primer tRNALys,3 in human cells expressing bacterial anticodon nuclease |
Q39593409 | Comparison of second-strand transfer requirements and RNase H cleavages catalyzed by human immunodeficiency virus type 1 reverse transcriptase (RT) and E478Q RT. |
Q38760919 | Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli formula supplied in trans |
Q40062231 | Conservation of tRNA mimicry in the 5'-untranslated region of distinct HIV-1 subtypes |
Q38362410 | Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). |
Q34529769 | Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA |
Q45422942 | Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1. |
Q42589496 | Defective replication in human immunodeficiency virus type 1 when non-primers are used for reverse transcription. |
Q38292600 | Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog |
Q36672092 | Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals |
Q36451947 | Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1 |
Q34344599 | Effect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity |
Q39879855 | Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1. |
Q33788773 | Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity |
Q59361002 | Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase |
Q36635791 | Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication |
Q35864780 | Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription |
Q61911604 | Effects of tRNA3Lys aminoacylation on the initiation of HIV-1 reverse transcription |
Q24673792 | Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation |
Q40393707 | Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus |
Q38362885 | Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. |
Q35861729 | Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection |
Q39991696 | Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme |
Q37633035 | Formation of the tRNALys packaging complex in HIV-1. |
Q37730594 | Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes. |
Q45722210 | Frequent dual initiation of reverse transcription in murine leukemia virus-based vectors containing two primer-binding sites. |
Q33887338 | Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein |
Q39548591 | Genetic dissociation of the encapsidation and reverse transcription functions in the 5' R region of human immunodeficiency virus type 1 |
Q39226845 | Glyceraldehyde 3-phosphate dehydrogenase negatively regulates human immunodeficiency virus type 1 infection |
Q40080869 | HIV-1 Exploits a Dynamic Multi-aminoacyl-tRNA Synthetase Complex To Enhance Viral Replication |
Q28307322 | HIV-1 RNA packaging |
Q38394900 | HIV-1 designed to use different tRNAGln isoacceptors prefers to select tRNAThr for replication |
Q34994062 | HIV-1 modulates the tRNA pool to improve translation efficiency |
Q37078563 | HIV-1 reverse transcription initiation: a potential target for novel antivirals? |
Q36856964 | HIV-1 reverse transcription: close encounters between the viral genome and a cellular tRNA. |
Q40284337 | Hairpin-induced tRNA-mediated (HITME) recombination in HIV-1. |
Q26767304 | Host RNA Packaging by Retroviruses: A Newly Synthesized Story |
Q24523263 | Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription |
Q35847385 | Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys) |
Q41125504 | Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription |
Q35823493 | Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA |
Q38309738 | Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers |
Q39877614 | Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met). |
Q30439541 | Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula |
Q36637578 | Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1. |
Q24529517 | Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1 |
Q36942505 | Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol |
Q37324137 | Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases. |
Q38613919 | Initiation of HIV Reverse Transcription |
Q38342940 | Interaction of retroviral reverse transcriptase with template-primer duplexes during replication. |
Q81793057 | Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex |
Q66679603 | LC/MS analysis and deep sequencing reveal the accurate RNA composition in the HIV-1 virion |
Q64078153 | Low-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo |
Q33837707 | Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity |
Q38353178 | Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis |
Q37320502 | New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3. |
Q36258296 | Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism |
Q28379170 | Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells |
Q35892473 | Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses |
Q39683830 | Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). |
Q24791889 | Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells |
Q39581407 | Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2Lys |
Q28775697 | Primer tRNAs for reverse transcription |
Q39796706 | Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replication |
Q42930396 | Profiling non-lysyl tRNAs in HIV-1. |
Q34354549 | Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability |
Q24675393 | Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys) |
Q35848047 | Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers |
Q33803814 | Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation. |
Q34353288 | Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs |
Q39683238 | Role of RNA in facilitating Gag/Gag-Pol interaction |
Q64228805 | Role of host tRNAs and aminoacyl-tRNA synthetases in retroviral replication |
Q39585566 | Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1. |
Q30651852 | Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication |
Q39326144 | Selective packaging of cellular miRNAs in HIV-1 particles |
Q35866117 | Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. |
Q38308590 | Specific binding of a hexanucleotide to HIV-1 reverse transcriptase: a novel class of bioactive molecules |
Q39996496 | Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1. |
Q35853488 | Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys |
Q41470121 | Structural and functional evidence that initiation and elongation of HIV-1 reverse transcription are distinct processes |
Q34364188 | Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex |
Q40429712 | Structural elements of the tRNA TPsiC loop critical for nucleocytoplasmic transport are important for human immunodeficiency virus type 1 primer selection |
Q42107901 | Switching the in vitro tRNA usage of HIV-1 by simultaneous adaptation of the PBS and PAS. |
Q37509321 | Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes |
Q40266291 | The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop |
Q26739938 | The Host RNAs in Retroviral Particles |
Q35215018 | The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome |
Q34999802 | The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein. |
Q24806162 | The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNA |
Q35155279 | The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells. |
Q35889392 | The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. |
Q34468488 | The role of A-kinase anchoring protein 95-like protein in annealing of tRNALys3 to HIV-1 RNA. |
Q30453508 | The role of Pr55(gag) in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNA |
Q39578385 | The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1. |
Q36548610 | The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA. |
Q39602865 | Transfer of primer binding site-mutated simian immunodeficiency virus vectors by genetically engineered artificial and hybrid tRNA-like primers. |
Q33814996 | Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein |
Q37504507 | Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors |
Q34625646 | Two step synthesis of (-) strong-stop DNA by avian and murine reverse transcriptases in vitro. |
Q33828332 | Vpr-host interactions during HIV-1 viral life cycle |
Q35857321 | tRNA isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral translation |
Search more.